Catherine Tucker
As Vice President of Business Development, Catherine Tucker is responsible for evaluating and driving the execution of strategic growth opportunities for BenevolentAI via partnerships and collaborations, and securing licensing deals. She and her team also ensure that robust opportunity and portfolio analysis and rigorous commercial thinking are applied throughout our pipeline to underpin future growth.
With over 20 years of experience in product development and commercialisation, business development, and strategic consulting in the pharmaceutical industry, Catherine has substantial breadth and depth of expertise in developing and commercialising products via licensing and strategic partnerships, and in driving corporate growth. Prior to joining BenevolentAI, Catherine held prominent global roles in pharmaceutical companies such as Allergan, BTG, UCB, Celltech, Elan, Schering-Plough and Boehringer Ingelheim.